Coming between a virus and its host
Nature Chemical Biology
May 17, 2010
Newly designed small molecules can inhibit HIV replication by blocking a viral-host interaction, reports a study published online this week in Nature Chemical Biology.
Interaction between the HIV-1 enzyme, integrase, and the cellular cofactor LEDGF/p75 plays a crucial role in viral integration. Zeger Debyser and colleagues design small molecules which block this interaction and inhibit HIV replication, even with HIV strains that are resistant to clinically used integrase inhibitors.
This work demonstrates a novel mechanism for inhibiting HIV integrase, and also illustrates the feasibility for the design of small molecules that inhibit protein-protein interaction between a viral protein and a cellular host factor.
doi: 10.1038/nchembio.370
Research highlights
-
Jul 30
Genetics: ENCODE expands the encyclopaedia of regulatory elementsNature
-
Jul 24
Drug repurposing: Large-scale screen reveals potential anti-SARS-CoV-2 drugsNature
-
Jul 23
Genomics: Six genomes provide clues to bats’ exceptional adaptationsNature
-
Jul 23
Biotechnology: A safer, rapid assay for studying SARS-CoV-2 neutralizing antibodiesNature Biotechnology
-
Jun 30
Biotechnology: Bioengineered scaffold repairs uterus and supports live births in rabbitsNature Biotechnology
-
Jun 24
Cancer: A 'fasting mimicking' diet may aid chemotherapyNature Communications
